Organizations must understand how to effectively use AI, identify its limitations, and introduce it in a way that complements the skills of the workforce. Additionally, investors are now favoring digitally savvy approaches.
Ensuring a robust data strategy is crucial to leveraging AI successfully. Without addressing this, CGT companies risk falling behind in this evolving tech landscape.
Join a select group of your industry peers as we discuss how to build a digital first strategy in advanced therapies.
This core segment of the virtual roundtable delves into the predetermined topic, facilitated by the moderator. Participants are encouraged to share insights, experiences, and perspectives, fostering a rich, collaborative dialogue. This hour-long discussion aims to share common challenges, explore solutions, trends, and innovative ideas.
2410 virtual roundtables are an exclusive forum that bring together life science executives to engage in candid discussion, share insight and collaborate on common challenges facing cell therapy developers today.
Facilitated by Michael Adeniya, a professional host with 15+ years in advanced therapies, you'll be an active participant in the discussion.
You'll leave with practical strategies to implement in your organization.
Enhance your approach and drive growth with insights gained from the roundtable. All gained from the comfort of your own office!
Kosten Digital’s mission is to revolutionize life sciences through digital transformation.
Founded by industry experts with over 40 years of experience in software development and biotech, we are redefining how technology solutions are built to drive innovation.
We develop custom technology solutions that empower life sciences organizations to optimize operations, leverage data, and enhance innovation through AI.
From early-stage startups to global corporations, we support clients at every stage of their digital journey.